UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 8-K/A
                                (Amendment No.1)

                                 CURRENT REPORT
                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934


        Date of Report (Date of earliest event reported): April 21, 2004

                          IR BIOSCIENCES HOLDINGS, INC.
                 (Exact name of registrant specified in charter)


    Delaware                        033-05384                   13-3301899
   (State of                    (Commission File               (IRS Employer
 Incorporation)                      Number)                Identification No.)
----------------        -------------------------------   ----------------------

                         4021 N. 75th Street, Suite 201
                              Scottsdale, AZ 85251
                              --------------------
               (Address of principal executive offices) (Zip Code)

                                 (480) 922-3926
                                 --------------
              (Registrant's telephone number, including area code)


                         ------------------------------
          (Former name or former address, if changed since last report

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))



ITEM 4.01  CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT



On April 21, 2004, upon  recommendation  of its Board of Directors,  the Company
dismissed its certifying accountant,  Stonefield Josephson, Inc. ("Stonefield").
Stonefield's  report on the  financial  statements of the Company for the period
from  October  30,  2002  (inception)  to  December  31, 2002 did not contain an
adverse  opinion or a disclaimer  of opinion or was  qualified or modified as to
uncertainty, audit scope or accounting principles.  However, the report included
an explanatory  paragraph wherein Stonefield  expressed  substantial doubt about
our ability to continue as a going  concern.  From July 15,  2003,  the date the
Company engaged Stonefield as its certifying accountant,  through April 21, 2004
the  Company  has not had any  disagreements  with  Stonefield  on any matter of
accounting  principles or practices,  financial statement disclosure or auditing
scope or procedure which if not resolved to the satisfaction of Stonefield would
have caused them to make reference to the subject matter of the disagreements in
connection  with their  reports on our  financial  statements.  The  Company has
engaged Russell Bedford  Stefanou  Mirchandani  LLP ("Russell  Bedford  Stefanou
Mirchandani")  as its  certifying  accountant  as of  April  21,  2004  for  the
Company's year ending  December 31, 2003. The Company has not consulted  Russell
Bedford Stefanou Mirchandani previously.

Stonefield's letter, which is required pursuant to Item 304(a)(3) of Regulation
S-B, is attached.





ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(c)      Exhibits:


Exhibit
Number                             Description
--------------  ----------------------------------------------------------------
16              Letter from Stonefield Josephson,  Inc.  Certified Public
                Accountants to the Commission, dated January 11, 2005.








                                    SIGNATURE

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                                   IR BioSciences Holdings, Inc.

Date: January 13, 2005                             By:  /s/ Michael Wilhelm
                                                   ----------------------------
                                                   Michael Wilhelm
                                                   President
                                                   (Duly Authorized Officer)









                                  Exhibit Index



Exhibit
Number                                 Description
--------------  ----------------------------------------------------------------
16              Letter from Stonefield Josephson,  Inc.  Certified Public
                Accountants to the Commission, dated January 11,  2005.